MGX (Metagenomi) Price-to-Tangible-Book : 0.23 (As of May. 08, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Price-to-Tangible-Book?

As of today (2025-05-08), Metagenomi's share price is $1.425. Metagenomi's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was $6.28. Hence, Metagenomi's Price to Tangible Book Ratio of today is 0.23.

The historical rank and industry rank for Metagenomi's Price-to-Tangible-Book or its related term are showing as below:

MGX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.22 Med: 0.58 Max: 0.58
Current: 0.23

During the past 4 years, Metagenomi's highest Price to Tangible Book Ratio was 0.58. The lowest was 0.22. And the median was 0.58.

MGX's Price-to-Tangible-Book is ranked better than
98.33% of 1201 companies
in the Biotechnology industry
Industry Median: 2.56 vs MGX: 0.23

A closely related ratio is called PB Ratio. As of today, Metagenomi's share price is $1.425. Metagenomi's Book Value per Sharefor the quarter that ended in Dec. 2024 was $6.28. Hence, Metagenomi's P/B Ratio of today is 0.23.

Metagenomi Price-to-Tangible-Book Historical Data

The historical data trend for Metagenomi's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi Price-to-Tangible-Book Chart

Metagenomi Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Price-to-Tangible-Book

0.58

Metagenomi Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Price-to-Tangible-Book	Get a 7-Day Free Trial						-	1.43	0.57	0.32	0.58

Competitive Comparison of Metagenomi's Price-to-Tangible-Book

For the Biotechnology subindustry, Metagenomi's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metagenomi's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Metagenomi's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Metagenomi's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Metagenomi Price-to-Tangible-Book Calculation

Metagenomi's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2024 )
	=	1.425	/	6.277
	=	0.23

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Metagenomi Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Metagenomi's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Metagenomi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

5959 Horton Street, 7th Floor, Emeryville, CA, USA, 94608

Website

https://metagenomi.co

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.